INHIBITEC

    News

    Slider

    Inhibitec Antibodies, S.L. Cantabrian bi…

    10-06-2019

    Inhibitec Anticuerpos, S.L. Cantabrian (Spain) biotechnology company, spin-off of the CSIC and University of Cantabria, has developed a monoclonal antibody for a new therapeutic target. Last week,  it was in...

    Read more